l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation (Q46904268)

From Wikidata
Jump to navigation Jump to search
scientific article published on 11 October 2007
edit
Language Label Description Also known as
English
l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation
scientific article published on 11 October 2007

    Statements

    l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit